Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/25 16:30 | 12/8/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Balcom Alexandra | MA | O | CFO | 6 | S.dm | -10,541 | 90.03 | 0 | -117 | 62 | D | |||||||||||||||
12/2/25 16:30 | 11/28/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 3 | S.d | -1,178 | 98.19 | 0 | -12 | 48 | D | |||||||||||||||
11/26/25 16:30 | 11/24/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Shair Matthew | MA | D | 2 | S.m | -6,836 | 101.27 | 0 | -68 | 1,586 | M | ||||||||||||||||
11/24/25 20:00 | 11/24/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | DTH | Director | 1 | S | -70,875 | 95.45 | 0 | -743 | 17,248 | I | |||||||||||||||
11/19/25 17:13 | 11/17/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Miller Deborah Ann | MA | O | GC | 4 | S.dm | -7,817 | 98.95 | 0 | -79 | 49 | D | |||||||||||||||
10/17/25 16:32 | 10/16/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 1 | S.d | -2,447 | 90.63 | 0 | -27 | 249 | D | |||||||||||||||
10/17/25 16:31 | 10/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Pelish Henry E. | MA | O | Chief Sc | 2 | S.dm | -2,174 | 89.54 | 0 | -24 | 66 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |